期刊文献+

系统性红斑狼疮并血栓病28例临床分析 被引量:1

Clinical Analysis of 28 Patients with Systemic Lupus Erythematosus Complicating Thrombus
下载PDF
导出
摘要 目的:探讨系统性红斑狼疮(SLE)血栓形成的危险因素。方法:回顾性分析SLE并血栓病28例的临床资料。结果:28例中男6例,女22例,男女之比为1:3.7;平均年龄(42.7±13.5)岁;平均病程(7.5±8.6)年;单因素分析显示:SLE-DAI、aCL、LDL-C、年龄、病程、男性、吸烟为血栓病的危险因素(P<0.05);多因素分析显示:病程、aCL、SLE-DAI是血栓病独立的危险因素(P<0.05)。结论:SLE患者的病程长、aCL阳性、SLE-DAI≥10分是合并血栓性疾病的独立危险因素。 Objective: To explore the risk factors of patients with systemic lupus erythematosus (SLE) complicating thrombosis. Methods: The clinical data of 28 patients with SLE complicating thrombus were analyzed retrospectively. Results: Among the 28 cases, male were 6 cases and female were 22 cases, male vs female ratio was 1:3.7. The average age was 42.7±13.5 years. The average life duration was 7.5±8.6 years. Single factor analysis showed that SLE-DAI, aCL, I,DL-C, age, duration, male, cigarette-smoking were risk factors for thrombus, all P〈 0.05. Multivariate analysis showed that duration, aCL,SLE-DAI were independent risk factors,all P〈0.05. Conslusion: Long-duration, aCL(+), SLE-DAI≥ 10 were independent risk factors for SLE complicating thrombus.
出处 《岭南急诊医学杂志》 2011年第1期30-32,共3页 Lingnan Journal of Emergency Medicine
基金 广东省医学科研基金(B2007056)
关键词 系统性红斑狼疮 血栓病 临床分析 systemic lupus erythematosus thrombosis clinical analysis
  • 相关文献

参考文献7

  • 1Mok MY, Chan EY, Fong DY, et al. Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus. J Rheumatol, 2005,32 (4) : 622.
  • 2郑文洁,赵岩,俞春霞,蒋颖,董怡,张奉春,唐福林.系统性红斑狼疮合并血栓或栓塞的临床分析[J].中华医学杂志,2003,83(17):1536-1537. 被引量:17
  • 3Somers E, Magder LS, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol, 2002,29 ( 12 ) : 2531.
  • 4Cervera R, Khamashta lVlA. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Mediline (Baltimore), 2003, 82(5) :299.
  • 5Tektonidou MG, Laskari K, Panagiotakos DB, et al.Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum, 2009,61 ( 1 ) :29.
  • 6el-Gamal YM, Heshnmt NM, el-Kerdany TH, et al. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis. Pediatr Allergy hnmunol, 2004,15 ( 3 ) : 270.
  • 7Ho KT, Ahn CW, Alarcon GS,et al. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events. Rheumatology (Oxford), 2005,44 (10) : 1303.

二级参考文献4

  • 1Kabakov AE, Tertov VV, Saenko VA, et al. The atherogenic effect of lupus sera. Clin Immunol Iummunopathol, 1992, 63:214-220.
  • 2Amigo MC, Khamashta MA, Antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Rheum Dis Clin North Am, 2000,26(2): 331-348.
  • 3Meroni PL, Riboldi P. Pathogenic mechanisms mediating Antiphospholipid syndrome. Curr Opin Rheumatol, 2001,13:377-382.
  • 4Ciard P, Musset D, Parent F, et al. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest, 1999,116:903-908.

共引文献16

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部